Fermer le menu


Member of Lyonbiopole


Founded in early 2005 by a group of senior managers with extensive drug discovery expertise gained in Life-Science organizations, Edelris is a privately-owned research and services company offering original natural product-like collections of screening compounds, innovative fragments for FBLD and efficient Hit to Lead and Lead optimisation capabilities.

Recent publications: 

Co-authored with Bayer: Isoform-Selective ATAD2 Chemical Probe with Novel Chemical Structure and Unusual Mode of Action

Co-authored with Nestlé Skin Health: New Caspase-1 inhibitor by scaffold hopping into bio-inspired 3D-fragment space


Strategic application domain: Human Medicine

Application market: Infectious Diseases, Oncology, Others

Type of activity: CRO - Tools - R&D platform, Technology provider

Technologies: Chemical synthesis services & medicinale chemistry, Screening methods or services, Small Molecules

Created on feb. 14th, 2005 - 60 employees



60, Avenue Rockefeller, Bioparc, Bioserra 1 Building 69008 Lyon



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.